Request Demo
Last update 23 Jan 2025
Beijing Neoletix Biological Technology
Last update 23 Jan 2025
Overview
Basic Info
Introduction Beijing Neoletix Biological Technology Co. Ltd. is a global enterprise pioneering in the biopharmaceutical industry, dedicated to the research of biologic therapeutics in the areas of hemostasis, thrombosis prevention, rare diseases, and oncology. Zhuangya Biotech has a sustained commitment to the development of innovative therapeutic approaches for hemostasis, antithrombotic treatments, and rare disease management. Additionally, the firm places a significant emphasis on the advancement of immune-targeted therapies for tumors and cancer. |
Tags
Other Diseases
Hemic and Lymphatic Diseases
Congenital Disorders
Recombinant protein
Recombinant coagulation factor
Nanobody
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
CTR20240584
评价重组人凝血因子Ⅷ在经治疗儿童重型血友病A患者（＜12岁）中预防治疗的安全性、有效性及药代动力学特征的单臂、开放、多中心临床试验
[Translation] A single-arm, open-label, multicenter clinical trial to evaluate the safety, efficacy, and pharmacokinetic characteristics of recombinant human coagulation factor VIII in the prevention and treatment of children with severe hemophilia A (<12 years old) who have been treated
CTR20231408
评价重组人凝血因子Ⅷ在经治疗重型血友病A患者（≥12岁）中按需治疗序贯预防治疗的安全性、有效性和药代动力学特征的单臂、开放、多中心临床试验
[Translation] A single-arm, open-label, multicenter clinical trial to evaluate the safety, efficacy, and pharmacokinetic characteristics of recombinant human coagulation factor VIII as an on-demand treatment for sequential prophylaxis in patients with severe hemophilia A (≥12 years old) who have been treated
100 Clinical Results associated with Beijing Neoletix Biological Technology
Login to view more data
Login to view more data
100 Deals associated with Beijing Neoletix Biological Technology
Login to view more data
100 Translational Medicine associated with Beijing Neoletix Biological Technology
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 24 Jan 2025
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
8
1
Preclinical
Phase 3 Clinical
1
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free